Inventor

MOOS WALTER H

US33 patents

⚠️ This page may combine multiple inventors who share the name “MOOS WALTER H”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MOOS WALTER H

WARNER LAMBERT CO

Apparatus for multiple simultaneous synthesis

Method of treating the symptoms of senile cognitive decline employing di- or trisubstituted urea cholinergic agents

Apparatus and method for multiple simultaneous synthesis

O-substituted tetrahydropyridine oxime cholinergic agents

Tetrahydropyridine oxime compounds

O-substituted tetrahydropyridine oxime cholinergic agents

Tetrasubstituted urea cholinergic agents

N6 -substituted adenosines for treating pain

N6 -substituted adenosines

Oxime and amine substituted azabicyclo and azocyclo muscarinic agonists and methods of treatment

Method of treating the symptoms of cognitive decline in an elderly patient employing (S)-3-ethyl-4-[(1-methyl-1H-imidazol-5-yl)-methyl]-2-oxazolidinone

Azabicyclo and azacyclo oxime and amine cholinergic agents and methods of treatment

Isotopically-labeled polycyclic amine derivatives

Substituted tetrahydro-3-pyridine-carboxylic acid, ester, and amide cholinergic agents

Derivatives of 1,2,3,4-tetrahydro-9-acrisinamine

4-(N-substituted amino)-2-butynyl-1-carbamates and thiocarbamates and derivatives thereof as centrally acting muscarinic agents

Method of treating senile cognitive decline with N&#39;-substituted aminopyridine adrenergic agents

Tetrahydropyridine oxime cholinergic agents and method of treatment

Azabicyclo and azacyclo oxime and amine cholinergic agents and methods of treatment

N6 -substituted adenosines and method of use

Azabicycloalkane oxime &amp; azabicycloalkene oxime muscarinic agents

Isotopically-labeled polycyclic amine derivatives

4-(N-substituted amino)-2-butynyl-1-ureas and thioureas and derivatives thereof as centrally acting muscarinic agents

Methods of treating depression and psychoses

CHIRON CORP

Synthesis of N-substituted oligomers

Synthesis of N-substituted oligomers

Opiate receptor ligands

Peptoid α-1 adrenergic receptor ligands

Peptoid alpha-1 adrenergic receptor ligands

MITOKOR

Mitochondria protecting agents for treating mitochondria associated diseases

Mitochondria protecting agents for treating mitochondria associated diseases

Compounds for altering mitochondrial function and cellular responses

MIGENIX CORP

Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor

Method of treating senile cognitive decline with N'-substituted aminopyridine adrenergic agents

Azabicycloalkane oxime & azabicycloalkene oxime muscarinic agents